Leo F Buckley (Leo Buckley)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 17

Top Venues

Arteriosclerosis, thrombosis, and vascular biology

Diabetes, obesity & metabolism

Kidney360

Journal of thrombosis and thrombolysis

Virginia Commonwealth University

Northeastern University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Virginia Commonwealth University Jul 01 2015 - Jun 30 2017

United States

Postdoctoral Fellow :: Pharmacotherapy and Outcomes Science

Brigham and Women's Hospital Jul 01 2014 - Jun 30 2015

United States

Cardiovascular Pharmacotherapy Resident :: Pharmacy Services

Brigham and Women's Hospital Jul 01 2013 - Jun 30 2014

United States

Pharmacy Practice Resident :: Pharmacy Services

Education History

Northeastern University

United States

PHD

Northeastern University

United States

BSC

Publications

Leo F Buckley, Peter Libby
Colchicine's Role in Cardiovascular Disease Management. Arteriosclerosis, thrombosis, and vascular biology 44 (5) (2024)
Leo F Buckley, Peter Libby
Colchicine's Role in Cardiovascular Disease Management. Arteriosclerosis, thrombosis, and vascular biology 44 (5) (2024)
Leo F Buckley, Peter Libby
Colchicine's Role in Cardiovascular Disease Management. Arteriosclerosis, thrombosis, and vascular biology 44 (5) (2024)
Leo F Buckley, Peter Libby
Colchicine's Role in Cardiovascular Disease Management. Arteriosclerosis, thrombosis, and vascular biology 44 (5) (2024)
Leo F Buckley, Peter Libby
Role of Colchicine in Cardiovascular Disease Management. Arteriosclerosis, thrombosis, and vascular biology (2024)
Yahya M K Tawfik, Benjamin W Van Tassell, Dave L Dixon, William L Baker, John Fanikos, Leo F Buckley
Effects of Intensive Systolic Blood Pressure Lowering on End-Stage Kidney Disease and Kidney Function Decline in Adults With Type 2 Diabetes Mellitus and Cardiovascular Risk Factors: A Post Hoc Analysis of ACCORD-BP and SPRINT. Diabetes care (2023)
Leo F Buckley, Ali M Agha, Pranav Dorbala, Brian Lee Claggett, Bing Yu, Aliza Hussain, Vijay Nambi, Lin Yee Chen, Kunihiro Matsushita, Ron C Hoogeveen, Christie M Ballantyne, Amil M Shah
MMP-2 Associates With Incident Heart Failure and Atrial Fibrillation: The ARIC Study. Circulation. Heart failure (2023)
John Fanikos, Kathleen Marquis, Leo F Buckley, Lena K Tran, Kevin C McLaughlin, Abby Jane Golash, Umberto Campia, Gregory Piazza, Jean Marie Connors, Samuel Z Goldhaber
Stability of alteplase for ultrasound-facilitated catheter-directed thrombolysis. Blood advances 5 (23) (2022)
Min Zhuo, Jiahua Li, Leo F Buckley, Sri Lekha Tummalapalli, David B Mount, David J R Steele, David J Lucier, Mallika L Mendu
Prescribing Patterns of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with CKD: A Cross-Sectional Registry Analysis. Kidney360 3 (3) (2022)
Abdullah A Alahmed, Julie C Lauffenburger, Muthiah Vaduganathan, Ahmed Aldemerdash, Clara Ting, Nayyra Fatani, John Fanikos, Leo F Buckley
Contemporary Trends in the Use of and Expenditures on Digoxin in the United States. American journal of cardiovascular drugs : drugs, devices, and other interventions 22 (5) (2022)
Leo F Buckley, William L Baker, Benjamin W Van Tassell, Jordana B Cohen, Omar S Alkhezi, Adam P Bress, Dave L Dixon
Systolic Blood Pressure Time in Target Range and Major Adverse Kidney and Cardiovascular Events. Hypertension (Dallas, Tex. : 1979) (2022)
Nayyra Fatani, Christopher Fanikos, Clara Ting, Leo F Buckley, John Fanikos
Use of P2Y12 inhibitors among Medicaid beneficiaries between 2008 and 2018. Journal of thrombosis and thrombolysis 48 (4) (2020)
Leo F Buckley
Correspondence on 'Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: a case-control study' by Potere et al. Annals of the rheumatic diseases (2020)
Leo F Buckley, Muthiah Vaduganathan, Julie C Lauffenburger, Sara R Machado, John Fanikos
Unintended Impact of US Food and Drug Administration Recalls on the Use of Contaminated and Non-Contaminated Angiotensin Receptor Blockers Among Medicaid Beneficiaries. The Annals of pharmacotherapy 54 (6) (2019)
Leo F Buckley, Dave L Dixon, George F Wohlford, Dayanjan S Wijesinghe, William L Baker, Benjamin W Van Tassell
Effect of intensive blood pressure control in patients with type 2 diabetes mellitus over 9 years of follow-up: A subgroup analysis of high-risk ACCORDION trial participants. Diabetes, obesity & metabolism 20 (6) (2018)
Salvatore Carbone, Justin M Canada, Hayley E Billingsley, Dinesh Kadariya, Dave L Dixon, Cory R Trankle, Leo F Buckley, Roshanak Markley, Chau Vo, Horacio Medina de Chazal, Sanah Christopher, Raffaella Buzzetti, Benjamin W Van Tassell, Antonio Abbate
Effects of empagliflozin on cardiorespiratory fitness and significant interaction of loop diuretics. Diabetes, obesity & metabolism 20 (8) (2018)
Benjamin W Van Tassell, Leo F Buckley, Salvatore Carbone, Cory R Trankle, Justin M Canada, Dave L Dixon, Nayef Abouzaki, Claudia Oddi-Erdle, Giuseppe Biondi-Zoccai, Ross Arena, Antonio Abbate
Interleukin-1 blockade in heart failure with preserved ejection fraction: rationale and design of the Diastolic Heart Failure Anakinra Response Trial 2 (D-HART2). Clinical cardiology 40 (9) (2017)

Leo F Buckley.css-eqlu8i{font-size:small;padding-left:4px;} (Leo Buckley)

Publication Activity (10 Years)

Top Topics

Top Venues

Leo F Buckley (Leo Buckley)